Nautilus Biotechnology (NAUT) Shares Outstanding (2020 - 2026)
Nautilus Biotechnology has reported Shares Outstanding over the past 7 years, most recently at $127.1 million for Q1 2026.
- Quarterly results put Shares Outstanding at $127.1 million for Q1 2026, up 0.73% from a year ago — trailing twelve months through Mar 2026 was $127.1 million (up 0.73% YoY), and the annual figure for FY2025 was $126.5 million, changed 0.29%.
- Shares Outstanding reached $127.1 million in Q1 2026 per NAUT's latest filing, roughly flat from $126.5 million in the prior quarter.
- Across five years, Shares Outstanding topped out at $127.1 million in Q1 2026 and bottomed at $124.5 million in Q1 2022.
- Median Shares Outstanding over the past 5 years was $125.3 million (2024), compared with a mean of $125.5 million.
- The largest annual shift saw Shares Outstanding soared 276.35% in 2022 before it increased 0.16% in 2023.
- Over 5 years, Shares Outstanding stood at $124.9 million in 2022, then rose by 0.16% to $125.1 million in 2023, then rose by 0.83% to $126.1 million in 2024, then rose by 0.29% to $126.5 million in 2025, then rose by 0.48% to $127.1 million in 2026.
- Business Quant data shows Shares Outstanding for NAUT at $127.1 million in Q1 2026, $126.5 million in Q4 2025, and $126.3 million in Q3 2025.